Prof. Dror Harats, the head of research at Sheba Medical Center at Tel Hashomer says the union with the U.S. National Institute of Health will expedite efforts that “lead to a vaccine and saving lives.”
According to the plan, Sheba will send the NIH’s Vaccine Research Center samples of blood, plasma, and the virus itself taken from corona patients examined in Israel, as well as all relevant information the hospital collects during the clinical studies it runs itself and in conjunction with international pharmaceutical companies.The NIH will supply Sheba with all the information it has on the virus in order to help expedite the medical center’s work.
Professor Dror Harats, chair of the Division for Research and Development and acting director of clinical trials at Sheba called the agreement a “major achievement for Sheba.”
Harats said he believed that the joint initiative would “lead to a vaccine and to saving lives.”
The weekly magazine noted the hospital’s breakthrough research in cardiology, gynecology, genetics, and medical education. Mention was also given to its specializations in rehabilitation, pediatrics, women’s health, post-traumatic stress disorder, and eating disorders.
View original Israel Hayom publication at:
Anyone interested in learning more about Sheba Medical Center, such as treatments and procedures, are invited to visit its website at: https://www.shebaonline.org/
‘as a light unto the nations’